Observational Study on the Effect of Switch to Lurasidone in Subjects With Schizophrenia "
Condition:   Schizophrenia Interventions:   Drug: Lurasidone;   Drug: aripiprazole, olanzapine, quetiapine or risperidone Sponsor:   Aziende Chimiche Riunite Angelini Francesco S.p.A Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2020 Category: Research Source Type: clinical trials

Intramuscular Ketamine Versus Aripiprazole and Escitalopram in the Treatment of Resistant Depression
Condition:   Depressive Disorder Interventions:   Drug: Ketamine;   Diagnostic Test: Cognition;   Other: Suicide risk;   Other: Depression thoughts;   Other: Quality of life and disability;   Other: Clinical and epidemiological factors;   Device: Safety of ketamine IM;   Other: Tolerability of ketamine IM Sponsor:   University of Sao Paulo Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 21, 2020 Category: Research Source Type: clinical trials

Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia Episode
Conditions:   Schizophrenia;   Schizoaffective Disorder, Depressive Type;   Schizophreniform Disorder Interventions:   Drug: Aripiprazole Lauroxil;   Drug: ARI-ORAL;   Drug: AL-NCD Sponsors:   University of California, Los Angeles;   Alkermes, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 18, 2019 Category: Research Source Type: clinical trials

A Trial of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolar 1 Disorder
Conditions:   Schizophrenia;   Bipolar I Disorder Intervention:   Drug: Aripiprazole Sponsors:   Otsuka Pharmaceutical Development& Commercialization, Inc.;   PRA Health Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 23, 2019 Category: Research Source Type: clinical trials

A Trial in Adult Subjects With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite ®
Condition:   Schizophrenia Intervention:   Combination Product: ABILIFY MYCITE Sponsor:   Otsuka Pharmaceutical Development& Commercialization, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2019 Category: Research Source Type: clinical trials